400-920-2911 sales@csnpharm.cn
CAS No.: 1260251-31-7
Synonyms: TL32711;SMAC mimetic;比瑞那帕
Birinapant binds with XIAP and cIAP1 with K of 45 and <1 nM, respectively.
生物活性
靶点 | cIAP1 Kd:1nM | XIAP Kd:45nM |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01486784 | Acute Myelogenous Leukemia | Phase 1 Phase 2 | Active, not recruiting | - | United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse << |
NCT01573780 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse << | Phase 1 | Terminated(Sponsor did not hav... more >>e funds to continue study) Collapse << | - | United States, New York ... more >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Collapse << |
NCT01766622 | Ovarian Neoplasms ... more >> Ovarian Cancer Fallopian Tube Neoplasms Fallopian Tube Cancer Collapse << | Phase 2 | Withdrawn | - | - |
实验方案
技术信息
CAS号 | 1260251-31-7 | 储存条件 |
|
|||||||
分子式 | C42H56F2N8O6 | 运输 | 蓝冰 | |||||||
分子量 | 806.94 | 别名 | TL32711;SMAC mimetic;比瑞那帕 | |||||||
溶解度 |
|
动物实验配方 |
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
451Lu | - | Growth Inhibition Assay | 72 h | IC50=14.2 nM, combined with 1ng/ml TNF-α | 23403634 |
Molm13 | 2/20/200 nM | Function Assay | 24 h | decreases cIAP1 and, to a much lesser extent, cIAP2, and XIAP under various conditions | 24526787 |
PANC-1 | 50/200/500 nM | Growth Inhibition Assay | 0-96 h | inhibits cell growth in both time and dose dependent manner | 26252969 |
WM1341D | - | Growth Inhibition Assay | 72 h | IC50=57.6 nM, combined with 1ng/ml TNF-α | 23403634 |
WM1366 | - | Growth Inhibition Assay | 72 h | IC50=7.9 nM, combined with 1ng/ml TNF-α | 23403634 |
WM164 | - | Growth Inhibition Assay | 72 h | IC50=9 nM, combined with 1ng/ml TNF-α | 23403634 |
WM1985 | - | Growth Inhibition Assay | 72 h | IC50=97 nM, combined with 1ng/ml TNF-α | 23403634 |
WM3130 | - | Growth Inhibition Assay | 72 h | IC50=64.3 nM, combined with 1ng/ml TNF-α | 23403634 |
WM3854 | - | Growth Inhibition Assay | 72 h | IC50=226 nM, combined with 1ng/ml TNF-α | 23403634 |
WM793B | - | Growth Inhibition Assay | 72 h | IC50=2.5 nM, combined with 1ng/ml TNF-α | 23403634 |
WM9 | - | Growth Inhibition Assay | 72 h | IC50=2.4 nM | 23403634 |
WM9 | - | Growth Inhibition Assay | 72 h | IC50=2.7 nM, combined with 1ng/ml TNF-α | 23403634 |
WTH202 | - | Growth Inhibition Assay | 72 h | IC50=1.8 nM, combined with 1ng/ml TNF-α | 23403634 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01486784 | Acute Myelogenous Leukemia | Phase 1 Phase 2 | Active, not recruiting | - | United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse << |
NCT01573780 | Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse << | Phase 1 | Terminated(Sponsor did not hav... more >>e funds to continue study) Collapse << | - | United States, New York ... more >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Collapse << |
NCT01766622 | Ovarian Neoplasms ... more >> Ovarian Cancer Fallopian Tube Neoplasms Fallopian Tube Cancer Collapse << | Phase 2 | Withdrawn | - | - |
NCT01681368 | Epithelial Ovarian Cancer ... more >> Peritoneal Neoplasms Fallopian Tube Neoplasms Collapse << | Phase 2 | Terminated(Accrual was termina... more >>ted for lack of a clinical benefit.) Collapse << | - | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse << |
NCT02756130 | High Grade Fallopian Tube Sero... more >>us Adenocarcinoma High Grade Ovarian Serous Adenocarcinoma Primary Peritoneal High Grade Serous Adenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse << | Phase 1 Phase 2 | Withdrawn(funding was not secu... more >>red) Collapse << | February 1, 2021 | United States, California ... more >> UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Collapse << |
NCT00993239 | Cancer | Phase 1 | Completed | - | United States, New York ... more >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Collapse << |
NCT01681368 | - | - | Terminated(Accrual was termina... more >>ted for lack of a clinical benefit.) Collapse << | - | - |
NCT02288208 | Hepatitis B | Phase 1 | Terminated(Due to cranial nerv... more >>e palsies observed) Collapse << | - | Australia, South Australia ... more >> CMAX / Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Nucleus Network Limited / AMREP Precinct Melbourne, Victoria, Australia, 3004 Australia, Western Australia Linear Clinical Research Ltd Nedlands, Western Australia, Australia, 6009 Collapse << |
NCT01188499 | - | - | Completed | - | - |
NCT02147873 | Myelodysplastic Syndrome (MDS)... more >> Chronic Myelomonocytic Leukemia (CMML) Collapse << | Phase 2 | Terminated(Study terminated du... more >>e to lack of efficacy) Collapse << | - | - |
NCT01188499 | Cancer | Phase 1 Phase 2 | Completed | - | United States, Florida ... more >> Holy Cross Hospital Fort Lauderdale, Florida, United States, 33308 United States, Michigan Barbara Ann Karmanos Cancer Center Detroit, Michigan, United States, 48201 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas Mary Crowley Cancer Research Center Dallas, Texas, United States, 75201 South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States, 78229 Collapse << |
NCT01940172 | Relapsed Epithelial Ovarian Ca... more >>ncer Relapsed Primary Peritoneal Cancer Relapsed Fallopian Tube Cancer Collapse << | Phase 1 | Completed | - | United States, California ... more >> TetraLogic research site Fresno, California, United States, 39720 TetraLogic Research Site San Luis Obispo, California, United States, 93401 United States, Kansas TetraLogic Research Site Fairway, Kansas, United States, 66205 United States, Massachusetts TetraLogic Research Site Boston, Massachusetts, United States, 02114 United States, North Carolina TetraLogic Research Site Durham, North Carolina, United States, 27710 United States, Pennsylvania TetraLogic Research Site Philadelphia, Pennsylvania, United States, 19107 TetraLogic Research Site Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee TetraLogic Research Site Nashville, Tennessee, United States, 37203 United States, Texas TetraLogic Research Facility Dallas, Texas, United States, 75201 Collapse << |
NCT02587962 | Solid Tumors | Phase 1 Phase 2 | Recruiting | June 2021 | United States, California ... more >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Monica Mita, MD United States, Florida Mid Florida Hematology and Oncology Center Recruiting Orange City, Florida, United States, 32763 Contact: Santosh Nair, MD United States, Maryland The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Dung Le, MD United States, Pennsylvania Thomas Jefferson University Sidney Kimmel Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Schilder Russel, MD United States, Texas Mary Crowley Cancer Research Recruiting Dallas, Texas, United States, 75251 Contact: James Strauss, MD MD Anderson Cancer Center, The University of Texas Recruiting Houston, Texas, United States, 77030 Contact: Siqing Fu, MD Collapse << |
NCT01828346 | Myelodysplastic Syndrome | Phase 1 Phase 2 | Completed | - | United States, Arizona ... more >> Palo Verde Hematology Oncology Glendale, Arizona, United States, 85304 Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259 United States, California California Cancer Associates for Research and Excellence Fresno, California, United States, 93720 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
靶点 | Description | IC50 |
---|---|---|
cIAP1 | Kd:1nM | |
XIAP | Kd:45nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网